Sclerosing Agent class drugs

2 results
  • asclera

    (POLIDOCANOL)
    Methapharm, Inc
    Asclera® (polidocanol) is indicated for the sclerotherapy of uncomplicated spider veins (≤1 mm) and reticular veins (1 to 3 mm) in the lower extremities. It is not approved for use in varicose veins greater than 3 mm in diameter.
  • varithena

    (polidocanol)
    Biocompatibles, Inc.
    VARITHENA (polidocanol injectable foam) is indicated for treating incompetent great saphenous veins and accessory saphenous veins, as well as visible varicosities in the GSV system. It relieves symptoms of superficial venous incompetence and improves the appearance of varicosities.